Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
50.90
+0.59 (1.17%)
At close: Feb 27, 2026

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
23,65017,23719,53016,03014,959-
Market Cap Growth
35.83%-11.74%21.83%7.16%--
Enterprise Value
22,78917,34218,89114,51814,805-
Last Close Price
50.9041.4747.8539.3737.01-
PS Ratio
38.9147.89213.94-1454.37-
PB Ratio
16.3886.1623.019.126.07-
P/TBV Ratio
22.83-50.5112.667.53-
EV/Sales Ratio
37.5048.18206.94-1439.37-
Debt / Equity Ratio
0.745.790.480.050.04-
Net Debt / Equity Ratio
-0.601.59-0.40-0.76-0.81-0.56
Net Debt / EBITDA Ratio
1.00-0.340.301.773.120.82
Net Debt / FCF Ratio
1.07-0.400.341.973.970.96
Asset Turnover
0.260.220.05-0.010.03
Inventory Turnover
0.810.350.54---
Quick Ratio
2.381.111.785.709.825.88
Current Ratio
2.471.272.035.939.966.06
Return on Equity (ROE)
-92.82%-179.21%-84.98%-34.87%-37.83%-76.72%
Return on Assets (ROA)
-24.53%-37.70%-40.35%-20.52%-21.46%-52.76%
Return on Capital Employed (ROCE)
-43.10%-103.90%-110.20%-43.20%-26.60%-70.80%
Earnings Yield
-3.67%-4.91%-5.67%-4.59%-4.48%-
FCF Yield
-3.40%-4.57%-5.12%-4.22%-3.35%-
Buyback Yield / Dilution
-5.52%-1.83%-0.70%-12.29%-0.07%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.